Progyny Balance Sheet Health

Financial Health criteria checks 6/6

Progyny has a total shareholder equity of $553.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $756.6M and $203.2M respectively. Progyny's EBIT is $62.2M making its interest coverage ratio -18.8. It has cash and short-term investments of $371.1M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-18.8x
CashUS$371.09m
EquityUS$553.43m
Total liabilitiesUS$203.19m
Total assetsUS$756.62m

Recent financial health updates

No updates

Recent updates

Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Apr 03
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Progyny: Long-Term Outlook Remains Positive, Reiterate Buy

Mar 15

Progyny: Long-Term Thesis Still Intact

Mar 09

Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Mar 01
Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Jan 07
Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Dec 11
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Nov 08
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Aug 24
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Aug 06
There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

May 06
Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Jan 25
When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Dec 12
Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Is It Time To Consider Buying Progyny, Inc. (NASDAQ:PGNY)?

Oct 18
Is It Time To Consider Buying Progyny, Inc. (NASDAQ:PGNY)?

Progyny Stock Should Deliver Superior Returns For Investors

Aug 05

Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Jul 27
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

At US$31.63, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Jul 08
At US$31.63, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Progyny: Solving Infertility Problem

Jul 05

Progyny Stock: A Hidden Gem Tackling Infertility

May 31

Investors Will Want Progyny's (NASDAQ:PGNY) Growth In ROCE To Persist

Apr 18
Investors Will Want Progyny's (NASDAQ:PGNY) Growth In ROCE To Persist

At US$50.90, Is It Time To Put Progyny, Inc. (NASDAQ:PGNY) On Your Watch List?

Mar 31
At US$50.90, Is It Time To Put Progyny, Inc. (NASDAQ:PGNY) On Your Watch List?

Earnings Not Telling The Story For Progyny, Inc. (NASDAQ:PGNY)

Mar 18
Earnings Not Telling The Story For Progyny, Inc. (NASDAQ:PGNY)

Financial Position Analysis

Short Term Liabilities: PGNY's short term assets ($640.4M) exceed its short term liabilities ($186.0M).

Long Term Liabilities: PGNY's short term assets ($640.4M) exceed its long term liabilities ($17.2M).


Debt to Equity History and Analysis

Debt Level: PGNY is debt free.

Reducing Debt: PGNY has no debt compared to 5 years ago when its debt to equity ratio was 2.3%.

Debt Coverage: PGNY has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: PGNY has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.